Selected article for: "IFNs type and regulation function"
Author: Cong, Wei; Zhang, Xiao-Xuan; He, Jun-Jun; Li, Fa-Cai; Elsheikha, Hany M.; Zhu, Xing-Quan
Title: Global miRNA expression profiling of domestic cat livers following acute Toxoplasma gondii infection
  • Document date: 2017_3_10
    • ID: 05tshufp_16
    Snippet: miR-126 is associated with tumorigenesis and has recently been found to modulate the survival and function of Plasmacytoid dendritic cells (pDCs) via positive regulation of the vascular endothelial growth factor (VEGF) signaling pathway [44] . miR-126 upregulation may activate Toll-like receptor (TLR)/MyD88 signalling in pDCs to secrete large amounts of type I interferons (IFNs), which is essential for host resistance to T. gondii infection. Also.....
    Document: miR-126 is associated with tumorigenesis and has recently been found to modulate the survival and function of Plasmacytoid dendritic cells (pDCs) via positive regulation of the vascular endothelial growth factor (VEGF) signaling pathway [44] . miR-126 upregulation may activate Toll-like receptor (TLR)/MyD88 signalling in pDCs to secrete large amounts of type I interferons (IFNs), which is essential for host resistance to T. gondii infection. Also, the biological significance of T. gondii-induced upregulation of miR-486 may lie in its ability to augment the host defense mechanisms. miR-486 has been shown to activate nuclear factor (NF)-κB signaling pathway [45] , which leads to the production of proinflammatory cytokines, thereby providing a protection against T. gondii infection. Of note, both miR-486 and the NF-κB signaling pathway have oncogenic roles in human cancers, such as glioma progression [45] .

    Search related documents:
    Co phrase search for related documents
    • nuclear factor and positive regulation: 1, 2, 3
    • nuclear factor and proinflammatory cytokine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • nuclear factor and proinflammatory cytokine production: 1, 2, 3
    • nuclear factor and signal pathway: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • nuclear factor and type interferon: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
    • nuclear factor and vascular VEGF endothelial growth factor: 1, 2, 3, 4, 5, 6, 7, 8
    • nuclear factor and VEGF endothelial growth factor: 1, 2, 3, 4, 5, 6, 7, 8
    • pdcs Plasmacytoid dendritic cell and Plasmacytoid dendritic cell: 1, 2, 3, 4, 5, 6, 7, 8
    • pdcs Plasmacytoid dendritic cell and type interferon: 1, 2
    • Plasmacytoid dendritic cell and signal pathway: 1
    • Plasmacytoid dendritic cell and type interferon: 1, 2, 3, 4, 5, 6
    • positive regulation and type interferon: 1, 2, 3, 4, 5
    • proinflammatory cytokine and signal pathway: 1
    • proinflammatory cytokine and type interferon: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • proinflammatory cytokine production and type interferon: 1, 2
    • signal pathway and type interferon: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • signal pathway and vascular VEGF endothelial growth factor: 1
    • signal pathway and VEGF endothelial growth factor: 1
    • vascular VEGF endothelial growth factor and VEGF endothelial growth factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73